Correlation between the clinical efficacy of donepezil HCL (E2020) and red blood cell (RBC) acetylcholinesterase (ACHE) inhibition in patients with Alzheimers disease (AD).

被引：0

|

作者：

Friedhoff, LT ^{[1
]}

Rogers, SL ^{[1
]}

机构：

[1] EISAI AMER INC, TEANECK, NJ USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1997年 / 61卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：PII49 / PII49

页数：1

相关论文

共 2 条

[1] MECHANISTIC INHIBITION STUDIES OF HUMAN RED BLOOD CELL (RBC) ACETYLCHOLINESTERASE (AChE) AND PLASMA BUTYRYLCHOLINESTERASE (BuChE) BY PHYSOSTIGMINE (PHYS), PHRIDOSTIGMINE (PYR), DONEPEZIL (DON) AND GALANTAMINE (GAL)
Lee, David S.
Venitz, Juergen
JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1103 - 1103
[2] RELATED DIFFERENCES IN IN- VITRO SENSITIVITY TO INHIBITION OF HUMAN RED BLOOD CELL ( RBC) ACETYLCHOLINESTERASE ( ACHE) AND PLASMA BUTYRYLCHOLINESTERASE ( BUCHE) BY THE CHOLINESTERASE ( CHE) INHIBITORS PHYSOSTIGMINE (PHYS), PYRIDOSTIGMINE ( PYR), DONEPEZIL ( DON) AND GALANTAMINE ( GAL).
Lee, D. S.
Venitz, J.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S15 - S15